Rossby Financial
RVMD icon

Rossby Financial’s Revolution Medicines RVMD Stock Holding History

Rossby Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$32K Buy
156
+56
+56% +$11.1K ﹤0.01% 1077
2026
Q2 		$18.7K Buy
100
+74
+285% +$10.8K ﹤0.01% 977
2026
Q1 		$2.56K Buy
26
+20
+333% +$2.02K ﹤0.01% 1743
2025
Q4 		$478 Buy
+6
New +$393 ﹤0.01% 1650

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Rossby Financial's RVMD Position: Q3 2026 in Review

Rossby Financial increased its Revolution Medicines (RVMD) stake by 56% in Q3 2026, buying an estimated $11.1K and bringing the position to 156 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Rossby Financial first reported a position in RVMD in Q4 2025 and has held it in 4 quarters since. 577 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Rossby Financial held 156 shares of Revolution Medicines worth $32K as of Q3 2026.
  • Rossby Financial bought 56 Revolution Medicines shares in Q3 2026, an estimated $11.1K.
  • Revolution Medicines made up ﹤0.01% of Rossby Financial's portfolio in Q3 2026, its #1077 holding.
  • Rossby Financial first reported a position in Revolution Medicines in Q4 2025 and has held it in 4 quarters since.
  • 577 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.